Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-FR
Language English French
Date Updated 2018-07-12 2018-04-30
Drug Identification Number 02388545 02388545
Brand name AURO-ALENDRONATE AURO-ALENDRONATE
Common or Proper name Alendronate Alendronate
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients ALENDRONIC ACID ALENDRONIC ACID
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2018-03-30 2018-03-30
Actual start date
Estimated end date 2018-05-18 2018-05-18
Actual end date 2018-05-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments